Soluble CD40 Ligand Measurement Inaccuracies Attributable to Specimen Type, Processing Time, and ELISA Method
Open Access
- 1 June 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (6) , 1054-1057
- https://doi.org/10.1373/clinchem.2005.048199
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Measurement of soluble P‐selectin and soluble CD40 ligand in serum and plasmaJournal of Thrombosis and Haemostasis, 2004
- The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromesClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaquesThe American Journal of Cardiology, 2004
- Upregulation of CD40–CD40 ligand system in patients with diabetes mellitusClinica Chimica Acta; International Journal of Clinical Chemistry, 2003
- Soluble CD40LCirculation, 2003
- Soluble CD40 Ligand in Acute Coronary SyndromesNew England Journal of Medicine, 2003
- Cardiopulmonary Bypass Induces Release of Soluble CD40 LigandCirculation, 2002
- Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosisBlood, 2002
- Soluble CD40L and Cardiovascular Risk in WomenCirculation, 2001
- Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable AnginaCirculation, 1999